GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹ २,६७९.९०
arrow_upward
+१.०६%(+२८.२०) 1D
नोभेम्बर १७, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
₹ २,६६७.००
High
₹ २,७२१.८०
Low
₹ २,६६३.७०
Mkt. cap
४.५३ खरब
Avg. vol.
८९.३८ हजार
Volume
७३.९८ हजार
Dividend
२.१३%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.५९
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
Open
₹ २,६६७.००
High
₹ २,७२१.८०
Low
₹ २,६६३.७०
Mkt. cap
४.५३ खरब
Avg. vol.
८९.३८ हजार
Volume
७३.९८ हजार
Dividend
२.१३%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.५९
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
ChartMill
·
५२ मिनेट पहिले
S&P 500 Losers: Software Stocks Lead Session Declines
Fox Business
·
१ घण्टा पहिले
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
MarketWatch
·
४२ मिनेट पहिले
Only two ‘Magnificent Seven’ stocks have managed to beat the S&P 500 since the start of 2025
Traders Union
·
१ घण्टा पहिले
Bitcoin-to-S&P 500 ratio holds trendline support, James Van Straten notes
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees३.१ हजार
Founded१९२४ नोभेम्बर १३
Headquarters-
SectorHealth Care
Industry-
Websiteindia-pharma.gsk.com